Advanced search
Publication Cover
Acta Orthopaedica Scandinavica Volume 70, 1999 - Issue sup285: The Scandinavian Sarcoma Group: Twenty years' experience
Journal homepage
104
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

The Scandinavian Sarcoma Group

Background, organization and the Central Register—the first 20 years

T A AlvegårdDept. of Oncology, Lund, Sweden
,
H BauerOrthopedic Oncology Service, Karolinska Hospital, Stockholm, Sweden
,
C BlomqvistDept. of Oncology, University Hospital, Helsinki, Finland
,
T MöllerSouthern Swedish Tumor Registry, Lund, Sweden
,
A RydholmDept. of Orthopedic Surgery, Lund, Sweden
&
G SaeterDept. of Oncology, The Norwegian Radium Hospital, Oslo, Norway
Pages 3-7 | Published online: 31 Aug 2016

  • Alho A, Alvegård T A, Berlin Ö, et al. for the Scandinavian Sarcoma Group. Surgical margin in soft tissue sarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand 1989; 60(6): 687–92.
  • Alvegård T A, Solheim Ø, Elomaa I. Ewing's sarcoma—a preliminary report from the Scandinavian Sarcoma Group. Acta Oncol 1989 (Suppl 2); 28: 59–64.
  • Alvegård T A, Solheim Ø, Åkerman M, Berg N O. Ewing's sarcoma. A preliminary report from the Scandinavian Sarcoma Group. Acta Orthop Scand 1989 (Suppl 2); 28: 59–64.
  • Alvegård T A. Management and prognosis of patients with high-grade soft tissue sarcomas. An evaluation of a Scandinavian joint care program. University of Lund (thesis), (1989) Lund.
  • Alvegård T A, Sigurdsson H, Mouridsen H, et al. Adjuvant chemotherapy with Doxorubicin in high-grade soft tissue sarcoma: A randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol 1989; 7: 1504–13.
  • Alvegård T A, Berg N O. Histopathology peer review of high-grade soft tissue sarcoma. The Scandinavian Sarcoma Group experience. J Clin Oncol 1989; 7: 1845–51.
  • Alvegård T A, Berg N O, Ranstam J, et al.. Prognosis in high-grade soft tissue sarcomas. The Scandinavian Sarcoma Group experience in a randomized adjuvant chemotherapy trial. Acta Orthop Scand 1989; 60(5): 517–21.
  • Alvegård T A, Berg N O, Baldetorp B, et al.. Cellular DNA content and prognosis of high grade soft tissue sarcoma. The Scandinavian Sarcoma Group experience. J Clin Oncol 1990; 8: 538–47.
  • Alvegård T A. List of publications from the Scandinavian Sarcoma Centers. Scandinavian Sarcoma secretariat. 1994; 125: 1989–93.
  • Elomaa I, Blomqvist C, Saeter G, et al. Three-year results of the SSG IX protocol in Ewing's sarcoma. Acta Orthop Scand 1994 (Suppl 262); 65: 77–8.
  • Elomaa I, Blomqvist C, Saeter G, et al. For the Scandinavian Sarcoma Group. Five-year results of the SSG IX protocol in Ewing's sarcoma. Med Ped Oncol 1996; 27(4): 225.
  • Gustafson P. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients. Acta Orthop Scand 1994 (Suppl 259); 65: 131.
  • Nilbert M, Saeter G, Elomaa I, Monge O, Wiebe T, Alvegård T. Ewing's sarcoma treatment in Scandinavia 1984–1990. Acta Oncol 1998; Vol 37 No 4; 375–78.
  • Rydholm A. Management of patients with soft-tissue tumors. Strategy developed at a regional oncology center. Acta Orthop Scand 1983 (Suppl 203); 54.
  • Rydholm A, Alvegård T. Scandinavian Sarcoma Group, Göteborg, Sweden, May 5–7, 1993. Acta Orthop Scand A 1994a (Suppl 265); 65: 55–72.
  • Rydholm A, Alvegård T A. Scandinavian Sarcoma Group, Helsinki, April 10–22, 1994. Acta Orthop Scand 1994b (Suppl 262); 65: 63–80.
  • Rydholm A, Alvegård T A. Scandinavian Sarcoma Group, Stockholm, April 26–28, 1995. Acta Orthop Scand 1995 (Suppl 265); 66: 89–100.
  • Rydholm A, Alvegård T A. Scandinavian Sarcoma Group, Reykjavik, May 7–9, 1996. Acta Orthop Scand 1996 (Suppl 272); 67: 41–59.
  • Rydholm A, Alvegård T A. Scandinavian Sarcoma Group, Trondheim, April 16–18, 1997. Acta Orthop Scand 1997 (Suppl 274); 68: 65–77.
  • Rydholm A, Alvegård T A. Scandinavian Sarcoma Group, Snekkersten, April 22–24, 1998. Acta Orthop Scand 1998 (Suppl 282); 69: 25–43.
  • Solheim Ø, Alvegård T A, Elomaa I. Adjuvant chemotherapy for osteosarcoma a preliminary report from the Scandinavian Sarcoma Group. Acta Oncol 1989 (Suppl 2); 28: 53–7.
  • Solheim Ø, Alvegård T A. The Scandinavian Sarcoma Group. 10 Years' experience. Acta Oncol 1989 (Suppl 2); 28: 175.
  • Solheim Ø, Saeter G, Elomaa I, Alvegård T A. The treatment of osteosarcoma: Present trends. The Scandinavian Sarcoma Group experience. Annals of Oncology 1992 (Suppl 2); 3: 711.
  • Saeter G, Alvegård T A, Elomaa I, et al.. Treatment of osteosarcoma of the extremities with the T10 protocol, with emphasis on the effects of preoperative chemotherapy with single agent high-dose methotrexate. A Scandinavian Sarcoma Group study. J Clin Oncol 1991; 9: 1766–75.
  • Saeter G, Strander H, Monge O R, Alvegård T A. Dose escalating etoposide (E), ifosfamide (I) and granulocyte colony stimulating factor (GCSF) (VIGregimen) in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group study. Ann Oncol 1994 (5 suppl); 8: 171.
  • Saeter G, Talle K, Solheim Ø. Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuos infusion etoposide. Cancer Chemotherapy and Pharmacology 1995; 36: 172–5.
  • Saeter G for the Scandinavian Sarcoma Group. Treatment of osteosarcoma with high-dose methotrexate containing neoadjuvant chemotherapy. Scandinavian Sarcoma Group data. Med Ped Oncol 1996a; 27(4): 263.
  • Saeter G for the Scandinavian Sarcoma Group. Treatment strategies and outcome in metastatic (relapsed) osteogenic sarcoma. The Scandinavian Sarcoma Group (SSG) experience. Med Ped Oncol 1996b; 27(4): 264.
  • Tierney J F, Mosseri V, Stewart L A, et al.. Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomized clinical trials. Br J Cancer 1995; 72: 469–75.
  • Tierney J F. Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma meta-analysis collaboration. Lancet 1997; Vol 350 No 9092, 1647–54.
  • Wiklund T A, Alvegård T A, Mouridsen H T, et al.. Marginal surgery and postoperative radiotherapy in soft tissue sarcomas. Eur J Cancer 1993; 29A: 30–69.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.